Kothari Fermentation & Biochem reported a net loss of ₹298.93 lakh for the financial year ended March 31, 2026, reversing the net profit of ₹80.99 lakh recorded in the previous year. The company's revenue from operations declined to ₹11,213.19 lakh for FY26, down from ₹11,423.10 lakh in the corresponding period of the previous year. Total income for the year stood at ₹11,286.87 lakh.

The Board of Directors approved the audited financial statements and results for the standalone financial year ended March 31, 2026, at a meeting held on May 29, 2026. The statutory auditors, M/s Kothari Kuldeep & Co., issued an audit report with an unmodified opinion on the financial results. The company also appointed M/s Arun K. Garg & Associates as internal auditors for FY 2026-27.

For the quarter ended March 31, 2026, the company reported a net profit of ₹127.26 lakh, a recovery from the net loss of ₹37.84 lakh in the quarter ended December 31, 2025. Revenue from operations for the fourth quarter was ₹3,246.80 lakh, slightly higher than the ₹3,217.87 lakh reported in the same quarter of the previous year. Total expenses for the full year increased to ₹11,633.10 lakh from ₹11,238.43 lakh in FY25.

Financial Performance

The company's earnings per share (EPS) for the full year was negative at ₹(1.99), compared to a positive EPS of ₹0.54 in the previous year. Basic and diluted EPS for the quarter ended March 31, 2026, stood at ₹0.85. The total comprehensive income for the year was a loss of ₹262.22 lakh, compared to an income of ₹66.46 lakh in the prior year.

Balance Sheet Highlights

The company's total assets stood at ₹12,654.72 lakh as of March 31, 2026, a marginal decrease from ₹12,791.66 lakh in the previous year. Non-current liabilities rose significantly to ₹5,468.54 lakh from ₹3,881.07 lakh, driven by an increase in borrowings to ₹4,279.66 lakh from ₹2,673.40 lakh. Current liabilities decreased to ₹1,791.27 lakh from ₹3,253.45 lakh, primarily due to a reduction in short-term borrowings.

Kothari Fermentation & Biochem Ltd. has announced that its board of directors will meet on Friday, May 29, 2026. The primary agenda of the meeting is to consider and approve the audited financial results of the company for the quarter and fiscal year ended March 31, 2026. The meeting is being convened in compliance with Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Closure of Trading Window

In accordance with the company's Code of Conduct for Prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's securities remains closed. This restriction applies to all designated persons and their immediate relatives. The window will reopen 48 hours after the declaration of the audited financial results for the period ending March 31, 2026. The company had previously communicated this closure via a notice dated March 24, 2026.

Meeting Details

The board meeting will address the financial performance for the fourth quarter and the full financial year 2025-26. Along with the financial results, the board may also take up other business items as necessary during the session.